Boucherville, Canada Clinical Trials

A listing of Boucherville, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 39 clinical trials
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

metastasis
measurable disease
stage iv non-small cell lung cancer
non-squamous non-small cell lung cancer
docetaxel
Investigational Site Number 1240004
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +168 other locations
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168

Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in participants with relapsing forms of MS Secondary Objective: To assess efficacy of SAR442168 compared to teriflunomide (Aubagio) on disability progression, MRI lesions, cognitive performance …

teriflunomide
urine test
multiple sclerosis
serum pregnancy test
pregnancy test urine
Investigational Site Number 1240005
 (7.8 away) Contact site
  • 0 views
  • 09 Sep, 2025
  • +24 other locations
An Efficacy and Safety Study of Ravulizumab in ALS Participants

The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.

riluzole
ravulizumab
edaravone
vaccination
Montreal Neurological Institute and Hospital
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

kras g12c mutation
ki-ras
solid tumor
kras
metastatic malignant solid tumor
Jewish General Hospital; Sir Mortimer B. Davis
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

prostatic neoplasm
measurable disease
prostatic neoplasms, castration-resistant
combined modality therapy
docetaxel
Centre hospitalier de l'Universit de Montr al (CHUM) Centre de Recherche
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk factors such as aging, obesity and unhealthy lifestyle. Paradoxically however, while lowering blood LDL, commonly known as "bad cholesterol", …

type 2 diabetes mellitus
fatty acids
insulin sensitivity/resistance
insulin
fish oil
Montreal Clinical Research Institute
 (8.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

replacement therapy
glycogen storage disease type ii
gaa gene
deficiency
myozyme
Investigational Site Number 124004
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

datscan
modafinil
methyldopa
resting tremor
parkinson's disease
McGill University
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
Pharmacokinetics Pharmacodynamics and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to …

SARS
acute respiratory syndrome (sars)
CHU Sainte-Justine
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +34 other locations